Bogle Investment Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Bogle Investment Management’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-212,150	Closed	-$2.77M	–	511
2016 Q2	$2.77M	Buy	+212,150	New	+$2.78M	0.19%	146
2015 Q4	–	Sell	-229,891	Closed	-$1.59M	–	481
2015 Q3	$1.59M	Buy	229,891 +18,469	+9%	+$158K	0.11%	206
2015 Q2	$2.08M	Buy	211,422 +162,316	+331%	+$1.48M	0.15%	170
2015 Q1	$435K	Sell	49,106 -316,907	-87%	-$2.52M	0.03%	297
2014 Q4	$3.21M	Buy	366,013 +142,966	+64%	+$1.16M	0.21%	143
2014 Q3	$1.54M	Buy	+223,047	New	+$1.34M	0.1%	207

Other funds holding SCLN

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bogle Investment Management's SCLN Position: Q3 2016 in Review

Bogle Investment Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q3 2016, closing a stake of 212,150 shares — an estimated $2.77M sold.

Bogle Investment Management first reported a position in SCLN in Q3 2014 and held it in 6 quarters. The position peaked at $3.21M in Q4 2014. 151 funds tracked by Wall St. Rank hold SCLN as of Q3 2016.

Bogle Investment Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
Bogle Investment Management sold 212,150 Sciclone Pharmaceuticals Inc shares in Q3 2016, an estimated $2.77M.
Bogle Investment Management first reported a position in Sciclone Pharmaceuticals Inc in Q3 2014 and held it in 6 quarters.
Bogle Investment Management's Sciclone Pharmaceuticals Inc position peaked at $3.21M in Q4 2014.
151 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2016.

Based on Bogle Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.